LGALS3 and neoplasm: Interestingly, Gal-3 is cleaved by matrix-metalloproteinases (MMPs) during tumor progression resulting in a Gal-3 variant, which lacks N-terminal amino acid residues 1–62 (Gal-3Δ) [37,38].